marissa miller fine post desvenlafaxine pristiq wyeth attempt cover bestseller effexor coming patent near future coverup considering desvenlafaxine clear knockoff effexor venlafaxine yes i sticking descriptor research develop innovative medication sell one quite highly similar one already sales blockbuster idea new make drug closely resembles existing product get fda approved slightly old one goes patent lexapro celexa invega risperdal effexor pristiq new drug offers advantage drug go generic would red ford pinto green pinto still crappy car patents supposed protect inventions possess potential benefit people patents supposed reward creativity creativity talking slight manipulation molecule create new compound better first one blame lie patent process physicians prone fall game many physicians prescribe lexapro escitalopram pert near clone celexa citalopram lexapro much pricey fact according walgreens pills mg generic citalopram run whereas supply lexapro costs marketing miracle constitutes heart soul modern psychiatry damn good convincing physicians newer equals better perhaps physicians received adequate training research methods statistics medical school could actually learn critically review clinical trial data discover ploy near clone medicines usually nothing increase costs doctors could also laugh way continuing medical education better yet insist cme start resemble education rather advertising